Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients

BACKGROUND: Xerostomia is a common adverse event of unknown etiology observed during pegylated interferon (PegIFN)/Ribavirin (Rbv) treatment. OBJECTIVES: To assess the frequency and mechanisms of xerostomia during PegIFN/Rbv therapy. PATIENTS AND METHODS: Thirty-one naïve patients with chronic hepat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aghemo, Alessio, Rumi, Maria Grazia, Monico, Sara, Banderali, Matteo, Russo, Antonio, Ottaviani, Francesco, Vigano, Mauro, D’Ambrosio, Roberta, Colombo, Massimo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Kowsar 2011
Soggetti:
Brief Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3269061/
https://ncbi.nlm.nih.gov/pubmed/22308157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/kowsar.1735143X.733
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi